JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB9614

Anti-IL-1 alpha 抗体

Anti-IL-1 alpha antibody

4

(3 Reviews)

|

(22 Publications)

Rabbit Polyclonal IL-1 alpha antibody. Suitable for IHC-P, ELISA, WB, sELISA, FuncS (Neut/Block), ICC/IF and reacts with Human, Recombinant full length protein, Recombinant full length protein - Human samples. Cited in 22 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human IL1A.

別名を表示する

IL1F1, IL1A, Interleukin-1 alpha, IL-1 alpha, Hematopoietin-1

3 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IL-1 alpha antibody (AB9614)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IL-1 alpha antibody (AB9614)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human liver tissue labelling IL-1 alpha with ab9614 at 1 μg/mL (45 minute incubation at room temperature). Heat mediated antigen retrieval was performed using a buffer at pH 6. An HRP-labeled polymer detection system was used with a DAB chromogen.

Sandwich ELISA - Anti-IL-1 alpha antibody (AB9614)
  • sELISA

Unknown

Sandwich ELISA - Anti-IL-1 alpha antibody (AB9614)
Western blot - Anti-IL-1 alpha antibody (AB9614)
  • WB

Unknown

Western blot - Anti-IL-1 alpha antibody (AB9614)

All lanes:

Western blot - Anti-IL-1 alpha antibody (ab9614) at 1 µg/mL

All lanes:

Recombinant human IL-1 alpha protein (<a href='/products/unavailable/recombinant-human-il-1-alpha-protein-ab73567'>ab73567</a>) at 0.01 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-preadsorbed-ab97080'>ab97080</a>) at 1/5000 dilution

Predicted band size: 31 kDa

true

Exposure time: 30s

Key facts

宿主種

Rabbit

クローン性

Polyclonal

アイソタイプ

Unknown

軽鎖のタイプ

unknown

キャリアフリー

No

交差種

Human

アプリケーション

ELISA, sELISA, FuncS (Neut/Block), ICC/IF, WB, IHC-P

applications

免疫原

Recombinant Full Length Protein corresponding to Human IL1A.

P01583

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "sELISA" : {"fullname" : "Sandwich ELISA", "shortname":"sELISA"}, "FuncSNeutBlock" : {"fullname" : "Functional Studies (Neut/Block)", "shortname":"FuncS (Neut/Block)"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1 µg/mL", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol.", "ELISA-species-checked": "predicted", "ELISA-species-dilution-info": "", "ELISA-species-notes": "", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "", "sELISA-species-checked": "guaranteed", "sELISA-species-dilution-info": "", "sELISA-species-notes": "", "FuncSNeutBlock-species-checked": "guaranteed", "FuncSNeutBlock-species-dilution-info": "", "FuncSNeutBlock-species-notes": "<p>To yield one-half maximal inhibition [ND50] of the biological activity of hIL-1a (20 ng/ml), a concentration of 1.0 - 2.0 μg/ml of this antibody is required.</p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Recombinant full length protein": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ELISA-species-checked": "guaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p>To detect hIL-1a by direct ELISA (using 100 μl/well antibody solution) a concentration of at least 0.5 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with compatible secondary reagents, allows the detection of 0.2 - 0.4 ng/well of recombinant hIL-1a.</p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "sELISA-species-checked": "notRecommended", "sELISA-species-dilution-info": "", "sELISA-species-notes": "", "FuncSNeutBlock-species-checked": "notRecommended", "FuncSNeutBlock-species-dilution-info": "", "FuncSNeutBlock-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Recombinant full length protein - Human": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ELISA-species-checked": "notRecommended", "ELISA-species-dilution-info": "", "ELISA-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p>To detect hIL-1a by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hIL-1a is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.</p>", "sELISA-species-checked": "testedAndGuaranteed", "sELISA-species-dilution-info": "0.5-2 µg/mL", "sELISA-species-notes": "<p>To detect IL-1 αlpha by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with <a href='/products/primary-antibodies/biotin-il-1-alpha-antibody-ab271226'>ab271226</a> as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant IL-1 αlpha.</p>", "FuncSNeutBlock-species-checked": "notRecommended", "FuncSNeutBlock-species-dilution-info": "", "FuncSNeutBlock-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

製品の詳細

This product is no longer batch tested in IHC, for an IHC validated antibody please see ab7632

出荷温度及び保存条件

製品の状態
Lyophilized
再構成
reconstitute with water at 200µL
精製方法
Affinity purification Immunogen
出荷温度
Blue Ice
短期保存温度
+4°C
長期保存温度
-20°C

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Cytokine constitutively present intracellularly in nearly all resting non-hematopoietic cells that plays an important role in inflammation and bridges the innate and adaptive immune systems (PubMed : 26439902). After binding to its receptor IL1R1 together with its accessory protein IL1RAP, forms the high affinity interleukin-1 receptor complex (PubMed : 17507369, PubMed : 2950091). Signaling involves the recruitment of adapter molecules such as MYD88, IRAK1 or IRAK4 (PubMed : 17507369). In turn, mediates the activation of NF-kappa-B and the three MAPK pathways p38, p42/p44 and JNK pathways (PubMed : 14687581). Within the cell, acts as an alarmin and cell death results in its liberation in the extracellular space after disruption of the cell membrane to induce inflammation and alert the host to injury or damage (PubMed : 15679580). In addition to its role as a danger signal, which occurs when the cytokine is passively released by cell necrosis, directly senses DNA damage and acts as a signal for genotoxic stress without loss of cell integrity (PubMed : 26439902).
See full target information IL1A

文献 (22)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 15:5423 PubMed38926338

2024

MRE11 and TREX1 control senescence by coordinating replication stress and interferon signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Hervé Técher,Diyavarshini Gopaul,Jonathan Heuzé,Nail Bouzalmad,Baptiste Leray,Audrey Vernet,Clément Mettling,Jérôme Moreaux,Philippe Pasero,Yea-Lih Lin

Fluids and barriers of the CNS 19:78 PubMed36171630

2022

The effect of A1 and A2 reactive astrocyte expression on hydrocephalus shunt failure.

Applications

Unspecified application

Species

Unspecified reactive species

Fatemeh Khodadadei,Rooshan Arshad,Diego M Morales,Jacob Gluski,Neena I Marupudi,James P McAllister,David D Limbrick,Carolyn A Harris

Head and neck pathology 16:763-772 PubMed35334093

2022

Comparison of Interleukin-1 Ligand Expression by Human Papilloma Virus Status in HNSCCs.

Applications

Unspecified application

Species

Unspecified reactive species

Ishrat Nourin Khan,Katherine N Gibson-Corley,Joseph D Coppock,Andrean L Simons

Circulation 144:893-908 PubMed34192892

2021

Interleukin-1α Is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney Disease.

Applications

Unspecified application

Species

Unspecified reactive species

Stefan J Schunk,Sarah Triem,David Schmit,Stephen Zewinger,Tamim Sarakpi,Ellen Becker,Gregor Hütter,Selina Wrublewsky,Fabienne Küting,Mathias Hohl,Dalia Alansary,Leticia Prates Roma,Peter Lipp,Julia Möllmann,Michael Lehrke,Matthias W Laschke,Michael D Menger,Rafael Kramann,Peter Boor,Willi Jahnen-Dechent,Winfried März,Michael Böhm,Ulrich Laufs,Barbara A Niemeyer,Danilo Fliser,Emmanuel Ampofo,Thimoteus Speer

Aging cell 19:e13198 PubMed32741087

2020

CD8 T cells are increased in the subventricular zone with physiological and pathological aging.

Applications

Unspecified application

Species

Unspecified reactive species

Manuel Moreno-Valladares,Leire Moreno-Cugnon,Tulio Mateo Silva,Juan Pablo Garcés,Ander Saenz-Antoñanzas,María Álvarez-Satta,Ander Matheu

Cell reports 31:107776 PubMed32579912

2020

Neurotoxic Reactive Astrocytes Drive Neuronal Death after Retinal Injury.

Applications

Unspecified application

Species

Unspecified reactive species

Kevin A Guttenplan,Benjamin K Stafford,Rana N El-Danaf,Drew I Adler,Alexandra E Münch,Maya K Weigel,Andrew D Huberman,Shane A Liddelow

Antioxidants (Basel, Switzerland) 9: PubMed32526964

2020

Baicalein Inhibits Benzo[a]pyrene-Induced Toxic Response by Downregulating Src Phosphorylation and by Upregulating NRF2-HMOX1 System.

Applications

Unspecified application

Species

Unspecified reactive species

Yuka Tanaka,Takamichi Ito,Gaku Tsuji,Masutaka Furue

Cancer management and research 11:10623-10632 PubMed31908534

2019

High Inflammatory Factor Grading Predicts Poor Disease-Free Survival in AJCC Stage I-II Hepatocellular Carcinoma Patients After R0 Resection.

Applications

Unspecified application

Species

Unspecified reactive species

Mao Zhang,Mei-Sze Chua,Jie Hu,Haoran Li,Shun Zhang,Liqun Wu,Bing Han

Journal of oncology 2019:5859680 PubMed31320902

2019

Impact of Nuclear Interleukin-1 Alpha and EGFR Expression on Recurrence and Survival Outcomes in Oral Squamous Cell Carcinomas.

Applications

Unspecified application

Species

Unspecified reactive species

Anand Rajan,Katherine N Gibson-Corley,Allen B Choi,Georgina K Ofori-Amanfo,Patrick Ten Eyck,Madelyn Espinosa-Cotton,Steven M Sperry,Andrean L Simons

Scandinavian journal of medicine & science in sports 29:1511-1520 PubMed31102473

2019

An in vitro investigation into the effects of 10 Hz cyclic loading on tenocyte metabolism.

Applications

Unspecified application

Species

Unspecified reactive species

Chineye P Udeze,Eleanor R Jones,Graham P Riley,Dylan Morrissey,Hazel R C Screen
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com